Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: September 10, 2025
Editor's Note: Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.
Journal: Cancer research
Published: March 21, 2025
A Randomized, Controlled Trial Evaluating Perioperative Risk-stratification and Risk-based, Protocol-driven Management After Elective Major Cancer Surgery.
Journal: Annals of surgery
Published: July 24, 2024
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 11, 2023
Discrepancies in survival after conversion to open in minimally invasive pancreatoduodenectomy.
Journal: American journal of surgery
Published: September 30, 2022
The effect of social determinants of health on utilization of surgical treatment for hepatocellular carcinoma patients.
Journal: American journal of surgery
Published: June 28, 2022
Risk of Lymph Node Metastasis in T1b Gastric Cancer: An International Comprehensive Analysis from the Global Gastric Group (G3) Alliance.
Journal: Annals of surgery
Published: December 16, 2021
Surgical management of biliary malignancy.
Journal: Current problems in surgery
Published: May 01, 2020
Combined Blockade of MEK and CDK4/6 Pathways Induces Senescence to Improve Survival in Pancreatic Ductal Adenocarcinoma.
Journal: Molecular cancer therapeutics
Published: November 06, 2019
Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer.
Journal: Molecular cancer therapeutics
Published: May 01, 2018
Last Updated: 09/26/2026